Alteration of cystatin C levels in cerebrospinal fluid of patients with Guillain-Barré Syndrome by a proteomical approach

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecular Biology Reports

• Publication date

  2009-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11033-008-9228-1PMID 18373213
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteomic analysis of the cerebrospinal fluid of patients with lumbar disk herniation

  2006cited by this paper
• The Role of Cystatin C in Cerebral Amyloid Angiopathy and Stroke: Cell Biology and Animal Models

  2006cited by this paper
• SeminarGuillain-Barré syndrome

  2005cited by this paper
• Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt‐Jakob disease

  2004cited by this paper
• Biochemistry and Clinical Role of Human Cystatin C

  2004cited by this paper
• Cystatin C as a cerebrospinal fluid biomarker for pain in humans

  2003cited by this paper
• cystatins: protein inhibitors of cysteine proteinases

  2001cited by this paper
• Dynamics of brain-derived proteins in cerebrospinal fluid.

  2001cited by this paper
• Cystatin C, an early indicator for incipient renal disease in rheumatoid arthritis.

  2000cited by this paper
• Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases

  2000cited by this paper
• Clinical and epidemiologic features of Guillain-Barré syndrome.

  1997cited by this paper
• Improved and simplified in‐gel sample application using reswelling of dry immobilized pH gradients

  1997cited by this paper
• The cerebral expression of plasma protein genes in different species.

  1995cited by this paper
• Assessment of current diagnostic criteria for Guillain‐Barré syndrome

  1990cited by this paper
• Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G‐250 and R‐250

  1988cited by this paper
• Development of polyacrylamide gels that improve the separation of proteins and their detection by silver staining.

  1988cited by this paper

• The Role of Adipokines in the Pathologies of the Central Nervous System

  2023cites this paper
• Current Biomarker Strategies in Autoimmune Neuromuscular Diseases

  2023cites this paper
• The relationship between serum cystatin C levels and Hughes motor scale in Guillain-Barré syndrome

  2022cites this paper
• CSF Diagnostics: A Potentially Valuable Tool in Neurodegenerative and Inflammatory Disorders Involving Motor Neurons: A Review

  2021cites this paper
• Mammalian cystatin and protagonists in brain diseases

  2020cites this paper
• Neuroprotection mediated by cystatin C-loaded extracellular vesicles

  2019cites this paper
• Identification of CSF biomarkers by proteomics in Guillain-Barré syndrome

  2018cites this paper
• Cerebrospinal fluid findings in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathies.

  2017cites this paper
• Cystatin C in aging and in Alzheimer's disease.

  2016cites this paper
• The expression features of serum Cystatin C and homocysteine of Parkinson's disease with mild cognitive dysfunction.

  2015cites this paper
• CSF Findings in Guillain-Barré Syndrome: Demyelinating and Axonal Acute Inflammatory Polyneuropathies

  2015cites this paper
• Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention

  2015cites this paper
• Association between serum cystatin C and diabetic peripheral neuropathy: a cross-sectional study of a Chinese type 2 diabetic population.

  2014cites this paper
• Proteome analysis of cerebrospinal fluid in healthy beagles and canine encephalitis.

  2012cites this paper
• Cystatin C in Alzheimer's disease

  2012cites this paper
• Cathepsins (S and B) and their inhibitor Cystatin C in immune cells: modulation by interferon-β and role played in cell migration.

  2011cites this paper
• Are Cerebrospinal Fluid Biomarkers Useful in Predicting the Prognosis of Multiple Sclerosis Patients?

  2011cites this paper
• Protective mechanisms by cystatin C in neurodegenerative diseases.

  2011cites this paper
• Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases.

  2010cites this paper
• Advances in proximal fluid proteomics for disease biomarker discovery.

  2010cites this paper
• Determination of cerebrospinal fluid cystatin C on Architect ci8200.

  2010cites this paper
• The influence of cerebrospinal fluid turnover on age-related changes in cerebrospinal fluid protein concentrations.

  2010cites this paper
• Proteome analysis of haptoglobin in cerebrospinal fluid of neuromyelitis optica

  2010cites this paper